ISPOR Tenth Annual Awards Recipients
Stephen L. Priori, Director, ISPOR Publications
At the ISPOR Tenth Annual International Meeting, May 15-18,
2005, Marriott Wardman Park Hotel, Washington, DC, the ISPOR
Awards Committee, chaired by C. Daniel Mullins, recognized
recipients of ISPOR Research Excellence Awards, Contributed
Paper Awards and Distinguished Service Awards.
The Second ISPOR Avedis Donabedian Outcomes Research Lifetime
Achievement Award
The ISPOR Avedis Donabedian Outcomes Research
Lifetime Achievement Award was established in honor of the late
Avedis Donabedian MD. Dr. Donabedian was a renowned faculty
member of the University of Michigan, School of Public Health
who dedicated his life to improving the quality of health care
and health care systems. After a long process that involved
nominations and selection of a panel of finalists, the ISPOR
Lifetime Achievement Awards Task Force, Chaired by Bryan Luce,
MBA, PhD, selected the recipient: Kathleen N, Lohr, PhD
Distinguished Fellow, Health Services Research RTI
International, RTP, NC, USA
ISPOR Avedis Donebedian Outcomes
Research Lifetime Achievement Award Chair
Bryan Luce PhD (l) and 2005 recipient
Kathleen N. Lohr PhD, MPhil
2005 ISPOR Bernie J.
O’Brien New Investigator Award
The ISPOR Bernie O’Brien New
Investigator Award was established in 2004 to honor the
long-standing commitment of Bernie J. O’Brien, PhD to training
and mentoring new scientists in the fields of outcomes research
and pharmacoeconomics. The ISPOR Bernie J. O’Brien New
Investigator Award Task Force, chaired by Michael Drummond, PhD,
selected the first ever recipient of this award: Shelby D. Reed
PhD, RPh Assistant Research Professor of Medicine Duke Clinical
Research Institute, Durham, NC, USA
ISPOR Bernie J. O’Brien
New Investigator
Award winner Shelby D. Reed PhD, RPh (l),
and ISPOR Bernie J. O’Brien New Investigator
Award Chair Michael F. Drummond
2005 ISPOR Research Excellence
Awards
The recipients of the 2005 ISPOR Research Excellence Award (one
for Methodology Excellence and one for Practical Application
Excellence) are selected by the Awards Committee based upon
publications that have appeared in respected peer-review
journals and other communication venues (e.g., books, reports)
during the preceding eighteen months from January 1 of the year
awarded. The award selection is based upon the publication’s
clear description of methods, along with the appropriate and
creative applications (or proposal thereof in conceptual
methodology work) of techniques to answer important questions in
the field of pharmacoeconomics and outcomes research. Such
publications will be expected to have much impact on the field,
due to their acceptance and application by others.
 And the
2005 recipient of the ISPOR Research Excellence Award
for
Methodology Excellence is…
Joshua Salomon, PhD as the senior
author of the research paper:
“A Multi-Method Approach to
Measuring Health- State Valuations.”
Health Econ 2004;13:281-90.
 And the 2005 recipient of the ISPOR Research Excellence Award
for Practical Application Excellence is…
Sebastian Schneeweiss MD, ScD as senior author of the research paper:
“Clinical and
Economic Consequences of a Formulary Restriction of Nebulized
Respiratory Drugs
in Adults: Direct Comparison of Randomized and
Observational Evaluations.”
Br Med J 2004;328:560-4.
A SPECIAL THANKS TO John Brooks, PhD, Chair, ISPOR Research Excellence
Award in Methodological Excellence and Joanna Siegel, ScD,
Chair, ISPOR Research Excellence Award in Practical Application
Excellence and their Task Forces for selecting the Recipients!
A
SPECIAL THANKS GOES TO Benjamin M. Craig PhD, Chair, ISPOR
Contributed Research Paper Awards Task Force -- Poster
Presentations, AS WELL AS TO Ya-Chen Tina Shih MS, PhD, Chair,
ISPOR Contributed Research Paper Awards Task Force -- Podium
Presentations, FOR ALL THEIR EFFORTS IN SELECTING THE WINNERS
And the recipients are... Best Contributed
Paper Awards Podium Presentations
MS3: ECONOMIC EVALUATION OF CONTROLLED-RELEASE OXYCODONE (OXYCONTIN
® TABLETS) (CRO) VERSUS OXYCODONE/ACETAMINOPHEN (PERCOCET ®)
(OXY/APAP) FOR OSTEOARTHRITIS PAIN OF THE HIP OR KNEE Marshall
DA1, Strauss ME2, Pericak D1, Buitendyk M1, Codding C3, Kim S2,
Torrance G1, 1Innovus Research Inc, Burlington, ON, Canada;
2Purdue Pharma L.P, Stamford, CT, USA; 3Oklahoma Sports,
Oklahoma City, OK, USA
IN3: COSTS OF DELIVERING ADULT INFLUENZA
VACCINATION IN NONTRADITIONAL SETTINGS
Prosser LA1, O’Brien MA1, Hohman KH1, Nichol KL2, Wortley PM3, Messonnier ML3, Molinari
NA3, Lieu TA1, 1Harvard Medical School, Boston, MA, USA; 2VA
Medical Center, Minneapolis, MN, USA; 3CDC, Atlanta, GA, USA
QL2: NEW WEIGHTS FOR OLD: A SCALE OF VALUES FOR EQ-5D HEALTH
STATES
Kind P, Macran S, Hennessy S, University of York, York,
UK Best New Investigator Podium Presentation
HP4: POTENTIALLY INAPPROPRIATE MEDICATION PRESCRIBING FOR
ELDERLY AMBULATORY PATIENTS IN REGIONE EMILIA ROMAGNA, ITALY
Maio V, Yuen EJ, Novielli KD, Rabinowitz C, Louis DZ, Jefferson
Medical College, Philadelphia, PA, USA
MS4: THE
COST-EFFECTIVENESS OF ADDING INFLIXIMAB TO USUAL THERAPY IN THE
TREATMENT OF PSORIATIC ARTHRITIS
Marra CA1, Maetzel A2, Farewell
VT3, Rashidi AA1, Shi P1, Antoni C4, Wong JB5, Gladman DD6,
1University of British Columbia, Vancouver, BC, Canada; 2Toronto
General Research Institute, Toronto, ON, Canada; 3Institute of
Public Health, Cambridge, UK; 4Schering-Plough Corporation,
Kenilworth, NJ, USA; 5Tufts-New England Medical Center, Boston,
MA, USA; 6Toronto Western Research Institute, Toronto, ON,
Canada IN4: COST EFFECTIVENESS OF HIV TREATMENT INNOVATIONS
OF GREATER EFFICACY THAN HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART)
Snedecor SJ1, Hartzema A1, Schiller KC2, 1Pharmacy Health Care
Administration, Gainesville, FL, USA; 2University of Florida,
Gainesville, FL, USA
Best Student Podium Presentation
CN3: ONCOLOGISTS’ COST-EFFECTIVENESS THRESHOLDS FOR NEW
CANCER THERAPIES
Nadler E1, Eckert B2, Neumann P2, 1Dana Farber
Cancer Institute, Boston, MA, USA; 2HarvardUniversity, Boston,
MA, USA
MH4: EFFECT OF SECOND-GENERATION ANTIDEPRESSANT
DISCONTINUATION ON DEPRESSIVE RELAPSE IN ADULT PATIENTS WITH
BIPOLAR DEPRESSION
Fu AZ, Christensen DB, Hansen RA, University
of North Carolina, Chapel Hill, NC, USA
CS8: ECONOMIC EVALUATION
OF ONDANSETRON VERSUS DIMENHYDRINATE FOR PREVENTION OF
POSTOPERATIVE VOMITING IN CHILDREN
Piwko C1, Lasry A1, Alanezi
K1, Coyte PC1, Ungar WJ2, 1University of Toronto, Toronto, ON,
Canada; 2The Hospital for Sick Children, Toronto, ON, Canada
Best Contributed Paper Awards Poster Presentations
PCN1:
META-ANALYSIS OF THE DIAGNOSTIC ACCURACY OF SCREENING TESTS FOR
COLORECTAL CANCER Slivinskas JC1, Gagnon YM1, Levy AR2, Enns
RA3, 1Oxford Outcomes, Vancouver, BC, Canada; 2University of
British Columbia, Vancouver, BC, Canada; 3St. Paul’s Hospital,
UBC, Vancouver, BC, Canada
PHP49: BRIEF SUMMARY FORMATS OF DTCA TO IMPROVE CONSUMER
COMPREHENSION
Sansgiry SS, Kawatkar AA, University of Houston,
Houston, TX, USA
PHP34: AN ASSESSMENT OF THE ASSOCIATION BETWEEN UNDERLYING
WORKER MEDICAL CONDITIONS AND WORKER ABSENTEEISM IN THE US
Mavros P1, Pietri G2, 1Merck & Co., Inc, Whitehouse Station, NJ,
USA; 2Rutgers University, Piscataway, NJ, USA
Best New Investigator Poster Presentation
PDB46: WILLINGNESS-TO-PAY FOR INHALED INSULIN - A CANADIAN
PERSPECTIVE
Sadri H, Health Outcome and Pharmacoeconomics
Research Centre, Toronto, ON, Canada
PDB25: DEPRESSION IN PATIENTS WITH TYPE 2 DIABETES: IMPACT ON
UTILIZATION PATTERNS AND ADHERENCE TO ORAL HYPOGLYCEMIC AGENTS
Kalsekar I1, Madhavan SM2, Amonkar M3, Douglas S2, Makela E2,
Scott V2, 1Butler University, Indianapolis, IN, USA; 2West
Virginia University, Morgantown, WV, USA; 3GlaxoSmithKline,
Collegeville, PA, USA PCV16: INCREMENTAL EFFECTS OF CONCURRENT
PHARMACOTHERAPEUTIC REGIMENS FOR HEART FAILURE ON
HOSPITALIZATIONS AND COSTS
Skrepnek GH1, Abarca J1, Malone DC1, Armstrong EP1, Shirazi FM2,
Woosley RL2, 1University of Arizona College of Pharmacy, Tucson,
AZ, USA; 2University of Arizona College of Medicine, Tucson, AZ,
USA
Best Student Poster Presentation
PCV33: MONITORING OF LIPID LEVELS AND ADVERSE EVENTS AMONG
TEXAS MEDICAID PATIENTS ON STATIN THERAPY
Dastani H1, Shepherd M1, Sasane R2, 1University of Texas,
Austin, TX, USA; 2AstraZeneca Pharmaceuticals LP, Wilmington,
DE, USA
PDB45: QUALITY OF LIFE (SF12), CLINICAL OUTCOMES, AND
COMORBID CONDITIONS IN PATIENTS WITH TYPE-2 DIABETES: A
POPULATION STUDY
Sundaram M, Kavookjian J, West Virginia University, Morgantown,
WV, USA
PCN2: SURVIVAL ANALYSIS OF PAIN RELIEF PROVIDED BY DOXEPIN
ORAL RINSE FOR ORAL MUCOSITIS PATIENTS Epstein JD1, Epstein JB2,
Epstein MS3, Oien HJ4, Truelove EL5, 1University of Southern
California, Los Angeles, CA, USA; 2University of Illinois,
Chicago, IL, USA; 3Fred Hutchison Cancer Research Center,
Seattle, WA, USA; 4Private General Dental Practice, Tualatin,
OR, USA; 5University of Washington, Seattle, WA, USA ISPOR
WOULD LIKE TO THANK ALL THE JUDGES WHO VOLUNTEERED THEIR TIME
AND EFFORTS DURING THE MEETING TO SCORE PODIUM AND POSTER
PRESENTATIONS ISPOR SERVICE AWARDEES
PRESIDENT (2003-2004) & PAST PRESIDENT (2004-2005)
Sean Sullivan
PhD, RPh, MS, Professor and Director, University of Washington,
Pharmaceutical Outcomes Research and Policy Program, Seattle,
WA, USA
DIRECTOR (2003-2005)
Randel Richner BSN, MPH, Vice President,
Federal Affairs, Reimbursement and Outcomes Planning, Boston
Scientific Corp, Natick, MA, USA
DIRECTOR (2003-2005)
Marcus Wilson PharmD, President & CEO, HealthCore Inc., Wilmington, DE, USA 19801-1366
TENTH ANNUAL INTERNATIONAL MEETING PROGRAM CHAIR
J. Jaime Caro
MD, Scientific Director, Caro Research, Concord, MA, USA
ISPOR SHORT COURSE DEVELOPMENT & QUALITY ASSURANCE TASK FORCE
CHAIR
(2001-2004) Lorne Baskin PharmD, Clinical Coordinator, North
Shore Medical Center, Cooper City, FL, USA
(1999-2001) Kati Copley-Merriman MBA, MS, Group Leader, Pfizer
Global Pharmaceuticals, Ann Arbor, MI, USA
ISPOR MANAGED
CARE_PBM SIG RESEARCH DIGEST WORKING GROUP CHAIR (2002-2004):
Dennis Raisch BS, MS, PhD, RPh, Associate Director, VA
Cooperative Studies Program, Albuquerque, NM, USA
For ISPOR MANAGED CARE OUTCOMES RESEARCH DIGEST
Yen-Huei (Tony) Tarn MS, PhD, Director General, Department of
Pharmacy, Taipei City Hospital, Taipei, Taiwan
For ISPOR PHARMACOECONOMIC GUIDELINES DATABASE
ISPOR GOOD
RESEARCH PRACTICES - ECONOMIC ANALYSIS ALONGSIDE CLINICAL TRIALS
TASK FORCE CHAIRS: Scott-Ramsey MD, PhD, Associate Member, Fred
Hutchinson Cancer Research Center, Seattle, WA, USA
Richard Wilke PhD, Senior Director, Group Leader, Global Outcome
Research, Pfizer, Inc., Peapack, NJ, USA
ISPOR GOOD RESEARCH PRACTICES - RETROSPECTIVE DATABASE
STUDIES TASK FORCE CHAIR:
Brenda Motheral MBA, PhD, Vice President, Express Scripts,
Maryland, Heights, MO, USA
QUALITY OF LIFE SIG - TRANSLATION & CULTURAL ADAPTATION
WORKING GROUP CHAIR:
Diane Wild, MSc, Oxford Outcomes, Cassington, Oxford, UK
For GOOD RESEARCH PRACTICES - QOL TRANSLATION & CULTURAL
ADAPTATION
ISPOR CODE OF ETHICS TASK FORCE CHAIR:
Francis Palumbo PhD, Executive Director and Professor,
University of Maryland, Center on Drugs and Public Policy,
Baltimore, MD, USA
ISPOR GOOD RESEARCH PRACTICES - MODELING STUDIES TASK FORCE
CHAIR:
Milton C. Weinstein PhD, Professor Health Policy & Management,
Harvard School of Public Health, Center for Risk Analysis,
Boston, MA,
USA STUDENT NETWORK CHAIR (2004-2005)
Larry Humble, Doctoral Student, University of Louisiana at
Monroe, Monroe, LA, USA ISPOR STUDENT CHAPTER PRESIDENTS
Florida A&M University - Chapter President
Tifini Preliou, Tallahassee, FL, USA
Ohio State University - Chapter President
Satish Valluri, Ohio, State College of Pharmacy, Columbus, OH,
USA
Purdue University - Chapter President
Hemant Phatak MS, West Lafayette, IN, USA
Rutgers University - Chapter President
Wing Chow PharmD, Bridgewater, NJ, USA
University of Arizona - Chapter President
Yuda Chongpison MBA, Tuscon, AX, USA
University of Florida - Chapter President
Cameron Schiller MS, Gainesville, FL, USA
University of Houston - Chapter President
Brinda Rao, Houston, TX, USA
University of Illinois-Chicago - Chapter President
Juan Blackburn MD, MBA, Chicago, IL, USA
University if Louisiana at Monroe- Chapter President
Rasmi Nair BS, MS, MBA, Monroe, LA, USA
University of Maryland - Chapter President
Navendu Samant, Baltimore, MD, USA
University of Michigan - Chapter President
Anish Patel, Ann Arbor, MI, USA
University of Minnesota - Chapter President
Joel Farley, Minneapolis, MN, USA
University of New Mexico - Chapter President
Upendra Abhyankar, MBA, College of Pharmacy, Albuquerque, NM,
USA
University of North Carolina at Chapel Hill - Chapter President
Melissa Butler, PharmD, MPH, Durham, NC, USA
University of Rhode Island - Chapter President>
Sarah Kachur, PharmD Candidate, Riverside, RI, USA
University of South Carolina - Chapter President
Margaret Franklin PharmD, Columbia, SC, USA
University of Southern California - Chapter President
Josh Epstein, Los Angels, CA, USA
University of Tennessee - Chapter President
Katherine Anderson MS, Memphis, TN, USA
University of Texas at Austin - Chapter President>
Esmond Nwokeji MBA, Austin, TX, USA
Virginia Commonwealth University - Chapter President
Anuprita Patkar MS, Pharm, Richmond, VA, USA
West Virginia University - Chapter President
Sanjoy Roy, Morgantown, WV, USA |
